All Stories

  1. What autoantigens induce Th17 cell differentiation in psoriasis?

    Article • Innate Immunity, May 2019, SAGE Publications

    Masutaka Furue

  2. Early pathology in venom-induced consumption coagulopathy by Rhabdophis tigrinus (Yamakagashi snake) envenomation

    Article • Clinical Toxicology, January 2019, Taylor & Francis

    Masutaka Furue

  3. Tryptophan Photoproduct FICZ Upregulates IL1A, IL1B, and IL6 Expression via Oxidative Stress in Keratinocytes

    Article • Oxidative Medicine and Cellular Longevity, November 2018, Hindawi Publishing Corporation

    Masutaka Furue

  4. Pharmacokinetic disposition of topical phosphodiesterase-4 inhibitor E6005 in patients with atopic dermatitis

    Article • Journal of Dermatological Treatment, November 2018, Taylor & Francis

    Maiko Nomoto, Dr Daisuke Onozuka, Masutaka Furue

  5. Thrombocytopenia in a psoriatic patient sequentially treated with adalimumab, secukinumab and ustekinumab

    Article • The Journal of Dermatology, October 2018, Wiley

    Masutaka Furue

  6. The IL-13/periostin/IL-24 pathway causes epidermal barrier dysfunction in allergic skin inflammation

    Article • Allergy, August 2018, Wiley

    Masutaka Furue

  7. NRF2 Activation Inhibits Both TGF-β1- and IL-13-Mediated Periostin Expression in Fibroblasts: Benefit of Cinnamaldehyde for Antifibrotic Treatment

    Article • Oxidative Medicine and Cellular Longevity, August 2018, Hindawi Publishing Corporation

    Masutaka Furue

  8. T helper type 2 signatures in atopic dermatitis

    Article • Journal of Cutaneous Immunology and Allergy, July 2018, Wiley

    Masutaka Furue

  9. Crystallization granuloma by nifekalant hydrochloride infusion

    Article • Geriatrics and Gerontology International, July 2018, Wiley

    Masutaka Furue

  10. Microbiome analysis of forehead skin in patients with atopic dermatitis and healthy subjects: Implication of Staphylococcus and Corynebacterium

    Article • The Journal of Dermatology, July 2018, Wiley

    Masutaka Furue

  11. Standardized reporting of the Eczema Area and Severity Index (EASI) and the Patient-Oriented Eczema Measure (POEM): a recommendation by the Harmonising Outcome Measures for Eczema (HOME) Initiative

    Article • British Journal of Dermatology, June 2018, Wiley

    Phyllis Spuls, Masutaka Furue

  12. Three cases of palmoplantar pustulosis successfully treated with apremilast

    Article • The Journal of Dermatology, June 2018, Wiley

    Masutaka Furue

  13. Epidermal barrier disruption by 9-hydroxy-10E,12Z-octadecadienoic acid in human keratinocytes

    Article • The Journal of Dermatology, June 2018, Wiley

    Masutaka Furue

  14. The diagnosis and management of extramammary Paget’s disease

    Article • Expert Review of Anticancer Therapy, March 2018, Taylor & Francis

    Masutaka Furue

  15. Autoimmunity and autoimmune co-morbidities in psoriasis

    Article • Immunology, February 2018, Wiley

    Masutaka Furue

  16. Mechanistic insights into topical tacrolimus for the treatment of atopic dermatitis

    Article • Pediatric Allergy and Immunology, January 2018, Wiley

    Masutaka Furue

  17. Perillaldehyde Inhibits AHR Signaling and Activates NRF2 Antioxidant Pathway in Human Keratinocytes

    Article • Oxidative Medicine and Cellular Longevity, January 2018, Hindawi Publishing Corporation

    Masutaka Furue

  18. Corrigendum to “Perillaldehyde Inhibits AHR Signaling and Activates NRF2 Antioxidant Pathway in Human Keratinocytes”

    Article • Oxidative Medicine and Cellular Longevity, January 2018, Hindawi Publishing Corporation

    Masutaka Furue

  19. Overexpression of S100A7 protein is an integral part of abnormal epidermal differentiation in cornoid lamella of porokeratosis

    Article • International Journal of Dermatology, December 2017, Wiley

    Masutaka Furue

  20. Air exposure may be associated with the histological differentiation of a cultured epidermal autograft (JACE)

    Article • Australasian Journal of Dermatology, December 2017, Wiley

    Masutaka Furue

  21. Early-onset epileptic encephalopathy and severe developmental delay in an association with de novo double mutations in NF1 and MAGEL2

    Article • Epilepsia Open, November 2017, Wiley

    Toshiro Hara, Takahiro Kato, Masutaka Furue

  22. Histopathological and genetic review of phosphaturic mesenchymal tumours, mixed connective tissue variant

    Article • Histopathology, November 2017, Wiley

    Mitsuru Takahashi, Masutaka Furue

  23. Clinical bandings of Patient-Oriented Eczema Measure scores among Japanese patients with atopic eczema

    Article • British Journal of Dermatology, October 2017, Wiley

    Masutaka Furue

  24. The pruritogenic mediator endothelin-1 shifts the dendritic cell-T-cell response toward Th17/Th1 polarization

    Article • Allergy, October 2017, Wiley

    Masutaka Furue

  25. Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis

    Article • Allergy, July 2017, Wiley

    Masutaka Furue

  26. Epidermal p16INK4aexpression is more frequently and intensely upregulated in lichen planus than in eczema, psoriasis, drug eruption and graft-versus-host disease

    Article • The Journal of Dermatology, March 2017, Wiley

    Masutaka Furue

  27. Pemphigus, a pathomechanism of acantholysis

    Article • Australasian Journal of Dermatology, February 2017, Wiley

    Masutaka Furue

  28. Melanoma therapy: Check the checkpoints

    Article • The Journal of Dermatology, January 2016, Wiley

    Masutaka Furue

  29. New Year's Greetings

    Article • The Journal of Dermatology, January 2016, Wiley

    Masutaka Furue

  30. Psoriasis: Behind the scenes

    Article • The Journal of Dermatology, January 2016, Wiley

    Masutaka Furue

  31. Bullous pemphigoid: What's ahead?

    Article • The Journal of Dermatology, November 2015, Wiley

    Masutaka Furue

  32. New aspects of the clinicopathological features and treatment of mycosis fungoides and Sézary syndrome

    Article • The Journal of Dermatology, October 2015, Wiley

    Masutaka Furue

  33. Galactomyces fermentation filtrate prevents T helper 2‐mediated reduction of filaggrin in an aryl hydrocarbon receptor‐dependent manner

    Article • Clinical and Experimental Dermatology, March 2015, Wiley

    Masutaka Furue

  34. Changes in sebum levels and the development of acneiform rash in patients with non–small cell lung cancer after treatment with EGFR inhibitors

    Article • OncoTargets and Therapy, January 2015, Taylor & Francis

    Masutaka Furue

  35. New Year's Greetings

    Article • The Journal of Dermatology, January 2015, Wiley

    Masutaka Furue

  36. Poor adherence to oral and topical medication in 3096 dermatological patients as assessed by the Morisky Medication Adherence Scale‐8

    Article • British Journal of Dermatology, December 2014, Wiley

    Dr Daisuke Onozuka, Masutaka Furue

  37. Antioxidant soybean tar G lyteer rescues T ‐helper‐mediated downregulation of filaggrin expression via aryl hydrocarbon receptor

    Article • The Journal of Dermatology, December 2014, Wiley

    Masutaka Furue

  38. Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: Results of a randomized, vehicle-controlled, multicenter clinical trial

    Article • The Journal of Dermatology, June 2014, Wiley

    Dr Nobukazu Hayashi, Dr Nobukazu Hayashi, Masutaka Furue

  39. Topical tacrolimus as treatment of atopic dermatitis

    Article • Clinical Cosmetic and Investigational Dermatology, November 2009, Taylor & Francis

    Masutaka Furue